Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.
Urine has become one of the most attractive biofluids in clinical proteomics, for its procurement is easy and noninvasive and it contains sufficient proteins and peptides. Urinary proteomics has thus rapidly developed and has been extensively applied to biomarker discovery in clinical diseases, especially kidney diseases. In this review, we discuss two important aspects of urinary proteomics in detail, namely, sample preparation and proteomic technologies. In addition, data mining in urinary proteomics is also briefly introduced. At last, we present several successful examples on the application of urinary proteomics for biomarker discovery in kidney diseases, including diabetic nephropathy, IgA nephropathy, lupus nephritis, renal Fanconi syndrome, acute kidney injury, and renal allograft rejection.
Wu
Jing
J
Department of Endocrinology and Metabolism, the Second Affiliated Hospital, Zhejiang University, Hangzhou, China.
Chen
Yi-ding
YD
Gu
Wei
W
D015415:Biomarkers / Q000378:metabolism*; D002853:Chromatography, Liquid / Q000379:methods; D019075:Electrophoresis, Capillary / Q000379:methods; D005199:Fanconi Anemia / Q000652:urine; D005260:Female; D005922:Glomerulonephritis, IGA / Q000652:urine; D006801:Humans; D007668:Kidney / Q000293:injuries; D007674:Kidney Diseases / Q000175:diagnosis* / Q000652:urine*; D008181:Lupus Nephritis / Q000652:urine; D008297:Male; D013058:Mass Spectrometry / Q000379:methods; D040081:Protein Array Analysis / Q000379:methods; D040901:Proteomics / Q000379:methods*; D014556:Urine
D015415:Biomarkers